Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Catella

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Neurology|September 12, 2001
Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effectsF Catella-Lawson
Coronary Artery Disease|February 1, 1997
Direct thrombin inhibitors in cardiovascular diseaseF Catella-Lawson
Thrombosis Research|September 15, 1987
Paired analysis of urinary thromboxane B2 metabolites in humansF Catella, G A FitzGerald
The American Journal of Medicine|February 15, 2001
Cyclooxygenase inhibition and thrombogenicityF Catella-Lawson, L J Crofford
Diabetes Research and Clinical Practice|February 1, 1996
Oxidative stress and platelet activation in diabetes mellitusF Catella-Lawson, G A FitzGerald
The American Journal of Medicine|August 25, 1986
Measurement of renal and non-renal eicosanoid synthesisF Catella, J Nowak, G A Fitzgerald
Human Pathology|March 1, 1987
Eicosanoid biosynthesis in human cardiovascular diseaseG A Fitzgerald, F Catella, J A Oates
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulationF Catella, D Healy, J A Lawson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolismP Patrignani, P Filabozzi, F Catella, et al.
The New England Journal of Medicine|October 16, 1986
Platelet activation in unstable coronary diseaseD J Fitzgerald, L Roy, F Catella, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Neurology|September 12, 2001
Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effectsF Catella-Lawson
Coronary Artery Disease|February 1, 1997
Direct thrombin inhibitors in cardiovascular diseaseF Catella-Lawson
Thrombosis Research|September 15, 1987
Paired analysis of urinary thromboxane B2 metabolites in humansF Catella, G A FitzGerald
The American Journal of Medicine|February 15, 2001
Cyclooxygenase inhibition and thrombogenicityF Catella-Lawson, L J Crofford
Diabetes Research and Clinical Practice|February 1, 1996
Oxidative stress and platelet activation in diabetes mellitusF Catella-Lawson, G A FitzGerald
The American Journal of Medicine|August 25, 1986
Measurement of renal and non-renal eicosanoid synthesisF Catella, J Nowak, G A Fitzgerald
Human Pathology|March 1, 1987
Eicosanoid biosynthesis in human cardiovascular diseaseG A Fitzgerald, F Catella, J A Oates
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulationF Catella, D Healy, J A Lawson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolismP Patrignani, P Filabozzi, F Catella, et al.
The New England Journal of Medicine|October 16, 1986
Platelet activation in unstable coronary diseaseD J Fitzgerald, L Roy, F Catella, et al.
Pageof 3